日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases

黑色素瘤脑转移中氧化磷酸化相关的临床、分子、代谢和免疫特征

Grant M Fischer, Renato A Guerrieri, Qianghua Hu, Aron Y Joon, Swaminathan Kumar, Lauren E Haydu, Jennifer L McQuade, Y N Vashisht Gopal, Barbara Knighton, Wanleng Deng, Courtney W Hudgens, Alexander J Lazar, Michael T Tetzlaff, Michael A Davies

Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases

分子分析揭示黑色素瘤脑转移的独特免疫和代谢特征

Grant M Fischer, Ali Jalali, David A Kircher, Won-Chul Lee, Jennifer L McQuade, Lauren E Haydu, Aron Y Joon, Alexandre Reuben, Mariana P de Macedo, Fernando C L Carapeto, Chendong Yang, Anuj Srivastava, Chandrashekar R Ambati, Arun Sreekumar, Courtney W Hudgens, Barbara Knighton, Wanleng Deng, Sheri

A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma

新型线粒体抑制剂阻断 MAPK 通路并克服黑色素瘤中的 MAPK 抑制剂耐药性

Y N Vashisht Gopal, Seth Gammon, Rishika Prasad, Barbara Knighton, Federica Pisaneschi, Jason Roszik, Ningping Feng, Sarah Johnson, Snigdha Pramanik, Jessica Sudderth, Dawen Sui, Courtney Hudgens, Grant M Fischer, Wanleng Deng, Alexandre Reuben, Weiyi Peng, Jian Wang, Jennifer L McQuade, Michael T T

A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid Tumors

一项多中心 I 期研究,评估 PX-866 和维莫非尼对晚期 BRAF V600 突变型实体瘤患者双重 PI3K 和 BRAF 抑制的效果

Clinton Yam, Xiaowei Xu, Michael A Davies, Phyllis A Gimotty, Jennifer J D Morrissette, Michael T Tetzlaff, Khalida M Wani, Shujing Liu, Wanleng Deng, Meghan Buckley, Jianhua Zhao, Ravi K Amaravadi, Naomi B Haas, Ragini R Kudchadkar, Anna C Pavlick, Jeffrey A Sosman, Hussein Tawbi, Luke Walker, Lynn

ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties

ALK 融合伙伴影响对 ALK 抑制的反应:对敏感性、细胞表型和生化特性的不同影响

Merrida A Childress, Stephen M Himmelberg, Huiqin Chen, Wanleng Deng, Michael A Davies, Christine M Lovly

Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy

PTEN缺失会促进对T细胞介导的免疫疗法的耐药性

Peng, Weiyi; Chen, Jie Qing; Liu, Chengwen; Malu, Shruti; Creasy, Caitlin; Tetzlaff, Michael T; Xu, Chunyu; McKenzie, Jodi A; Zhang, Chunlei; Liang, Xiaoxuan; Williams, Leila J; Deng, Wanleng; Chen, Guo; Mbofung, Rina; Lazar, Alexander J; Torres-Cabala, Carlos A; Cooper, Zachary A; Chen, Pei-Ling; Tieu, Trang N; Spranger, Stefani; Yu, Xiaoxing; Bernatchez, Chantale; Forget, Marie-Andree; Haymaker, Cara; Amaria, Rodabe; McQuade, Jennifer L; Glitza, Isabella C; Cascone, Tina; Li, Haiyan S; Kwong, Lawrence N; Heffernan, Timothy P; Hu, Jianhua; Bassett, Roland L Jr; Bosenberg, Marcus W; Woodman, Scott E; Overwijk, Willem W; Lizée, Gregory; Roszik, Jason; Gajewski, Thomas F; Wargo, Jennifer A; Gershenwald, Jeffrey E; Radvanyi, Laszlo; Davies, Michael A; Hwu, Patrick

BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma

BRAFV600E 选择保守的 MHC I 类内化途径来减少黑色素瘤的抗原呈递和 CD8+ T 细胞识别

Sherille D Bradley, Zeming Chen, Brenda Melendez, Amjad Talukder, Jahan S Khalili, Tania Rodriguez-Cruz, Shujuan Liu, Mayra Whittington, Wanleng Deng, Fenge Li, Chantale Bernatchez, Laszlo G Radvanyi, Michael A Davies, Patrick Hwu, Gregory Lizée

Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanoma

靶向N-钙黏蛋白可增加血管通透性,并在黑色素瘤中差异性激活AKT。

Turley, Ryan S; Tokuhisa, Yoshihiro; Toshimitsu, Hiroaki; Lidsky, Michael E; Padussis, James C; Fontanella, Andrew; Deng, Wanleng; Augustine, Christina K; Beasley, Georgia M; Davies, Michael A; Dewhirst, Mark W; Tyler, Douglas S

Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target

患者匹配的脑和颅外黑色素瘤转移的分子分析表明 PI3K 通路可作为治疗靶点

Guo Chen, Nitin Chakravarti, Kimberly Aardalen, Alexander J Lazar, Michael T Tetzlaff, Bradley Wubbenhorst, Sang-Bae Kim, Scott Kopetz, Alicia A Ledoux, Y N Vashisht Gopal, Cristiano Goncalves Pereira, Wanleng Deng, Ju-Seog Lee, Katherine L Nathanson, Kenneth D Aldape, Victor G Prieto, Darrin Stuart

Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set

对 NCI 60 株癌细胞系的蛋白质组学特征、突变和药物反应性进行整合分析

Park, Eun Sung; Rabinovsky, Rosalia; Carey, Mark; Hennessy, Bryan T; Agarwal, Roshan; Liu, Wenbin; Ju, Zhenlin; Deng, Wanleng; Lu, Yiling; Woo, Hyun Goo; Kim, Sang-Bae; Cheong, Jae-Ho; Garraway, Levi A; Weinstein, John N; Mills, Gordon B; Lee, Ju-Seog; Davies, Michael A